PRESS RELEASE
22 April 2025

Brink Therapeutics Raises €3.5 Million

GP
Goodwin Procter LLP

Contributor

At Goodwin, we partner with our clients to practice law with integrity, ingenuity, agility, and ambition. Our 1,600 lawyers across the United States, Europe, and Asia excel at complex transactions, high-stakes litigation and world-class advisory services in the technology, life sciences, real estate, private equity, and financial industries. Our unique combination of deep experience serving both the innovators and investors in a rapidly changing, technology-driven economy sets us apart.
The Paris Life Sciences and Technology team advised Kurma Partners and Breega on the €3.5 million fundraising of Paris-based biotech startup, Brink Therapeutics.
France

The Paris Life Sciences and Technology team advised Kurma Partners and Breega on the €3.5 million fundraising of Paris-based biotech startup, Brink Therapeutics.

Using an approach combining directed evolution, metagenomic exploration and artificial intelligence, Brink Therapeutics designs enzymes capable of inserting, deleting or modifying DNA sequences with unprecedented precision, paving the way for safer and more effective gene therapies.

This seed financing round was led by investors Kurma Partners and Breega, as well as Kima Ventures, Plug and Play Ventures, and well-known business angels in the healthcare and artificial intelligence sectors.

The Goodwin team was led by Anne-Charlotte Rivière and included Charlotte Muller, Marie Fillon, Louis de Chezelles and Albana Taipi.

Contributor

At Goodwin, we partner with our clients to practice law with integrity, ingenuity, agility, and ambition. Our 1,600 lawyers across the United States, Europe, and Asia excel at complex transactions, high-stakes litigation and world-class advisory services in the technology, life sciences, real estate, private equity, and financial industries. Our unique combination of deep experience serving both the innovators and investors in a rapidly changing, technology-driven economy sets us apart.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More